Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.001 per share TDOC New York Stock Exchange ______________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________________________________________________ Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period en ...

Teladoc Health, Inc. (NYSE:TDOC) Q2 2024 Earnings Conference Call July 31, 2024 4:30 PM ET Company Participants Chuck Divita - Chief Executive Officer Mala Murthy - Chief Financial Officer Michael Minchak - Head of Investor Relations Conference Call Participants Lisa Gill - J.P. Morgan Stephanie Davis - Barclays Jess Tassan - Piper Sandler Jailendra Singh - Truist Securities Richard Close - Cannacord Genuity Elizabeth Anderson - Evercore ISI Sarah James - Cantor Fitzgerald Sean Dodge - RBC Capital Markets ...

For the quarter ended June 2024, Teladoc (TDOC) reported revenue of $642.44 million, down 1.5% over the same period last year. EPS came in at -$0.28, compared to -$0.40 in the year-ago quarter. The reported revenue represents a surprise of -1.06% over the Zacks Consensus Estimate of $649.34 million. With the consensus EPS estimate being -$0.36, the EPS surprise was +22.22%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street ...

2Q-24 Quarterly Results Cautionary Note • This presentation contains, and the officers of Teladoc Health, Inc. (the "Company" or "Teladoc Health") may make, "forward-looking" statements that are based on management's beliefs and assumptions and on information currently available to management. These forward-looking statements include, without limitation, information concerning possible or assumed future results of operations, including descriptions of the Company's business plan and strategies. These statem ...

Exhibit 99.1 Teladoc Health Reports Second Quarter 2024 Results PURCHASE, NY, July 31, 2024—Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the three months ended June 30, 2024 ("Second Quarter 2024"). Unless otherwise noted, percentage and other changes are relative to the three months ended June 30, 2023 ("Second Quarter 2023"). Financial and Operational Highlights for Second Quarter 2024 • Second Quarter 2024 revenue of $642.4 millio ...

Teladoc Health, Inc. (TDOC) is set to report its second-quarter 2024 results on Jul 31, after the closing bell. The Zacks Consensus Estimate for second-quarter earnings is currently pegged at a loss of 35 cents per share, implying an improvement of 12.5% from the year-ago reported number. The estimate remained stable over the past week. The Zacks Consensus Estimate for second-quarter revenues is currently pegged at $649.6 million, suggesting a 0.4% fall from the year-ago actuals. TDOC beat the consensus est ...

The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe. While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights. Analysts predict that the 'Revenues by Segment- BetterHelp' will reach $273.85 million. Th ...

Teladoc Health Today | --- | --- | |---------------------|-------| | | | | | | | TDOC Teladoc Health | | | $9.30 | | | +0.11 (+1.20%) | | | | | | 52-Week Range $8.73 | | | ▼ | | | $30.41 | | | Price Target $17.97 | | | | | Add to Watchlist Virtual healthcare provider Teladoc Health Inc. NYSE: TDOC stock is trading down 57.8% year-to-date (YTD). The collapse occurred after reporting Q4 2023 earnings, which were further accelerated by its Q1 2024 earnings miss and lowered guidance. This once promising telehea ...

The latest trading session saw Teladoc (TDOC) ending at $9.30, denoting a +1.2% adjustment from its last day's close. The stock outperformed the S&P 500, which registered a daily loss of 0.16%. At the same time, the Dow lost 0.14%, and the tech-heavy Nasdaq lost 0.06%. For the annual period, the Zacks Consensus Estimates anticipate earnings of -$1.05 per share and a revenue of $2.65 billion, signifying shifts of +21.64% and +1.8%, respectively, from the last year. The Zacks Rank system, running from #1 (Str ...

PURCHASE, NY, July 17, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release second quarter 2024 results on Wednesday, July 31, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain avai ...